HLB Co. Ltd (028300) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.024x

Based on the latest financial reports, HLB Co. Ltd (028300) has a cash flow conversion efficiency ratio of -0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-11.08 Billion ≈ $-7.51 Million USD) by net assets (₩452.86 Billion ≈ $306.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

HLB Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how HLB Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read HLB Co. Ltd (028300) financial obligations for a breakdown of total debt and financial obligations.

HLB Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HLB Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Porsche Automobil Holding SE
F:PAHA
-0.006x
Firefly Aerospace Inc. Common Stock
NASDAQ:FLY
-0.057x
Yang Ming Marine Transport Corp
TW:2609
0.033x
Bharat Dynamics Limited
NSE:BDL
-0.019x
Sundaram Finance Limited
NSE:SUNDARMFIN
-0.203x
Patanjali Foods Limited
NSE:PATANJALI
-0.048x
TECHNOLOGY ONE LTD.
F:RW8
N/A
Home BancShares Inc
NYSE:HOMB
0.030x

Annual Cash Flow Conversion Efficiency for HLB Co. Ltd (2010–2024)

The table below shows the annual cash flow conversion efficiency of HLB Co. Ltd from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see 028300 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩576.57 Billion
≈ $390.73 Million
₩-114.31 Billion
≈ $-77.47 Million
-0.198x -3.41%
2023-12-31 ₩582.25 Billion
≈ $394.58 Million
₩-111.63 Billion
≈ $-75.65 Million
-0.192x -97.86%
2022-12-31 ₩637.94 Billion
≈ $432.32 Million
₩-61.82 Billion
≈ $-41.89 Million
-0.097x +22.86%
2021-12-31 ₩435.96 Billion
≈ $295.44 Million
₩-54.77 Billion
≈ $-37.11 Million
-0.126x -6.64%
2020-12-31 ₩479.75 Billion
≈ $325.12 Million
₩-56.51 Billion
≈ $-38.30 Million
-0.118x +55.24%
2019-12-31 ₩184.89 Billion
≈ $125.30 Million
₩-48.66 Billion
≈ $-32.97 Million
-0.263x -57.63%
2018-12-31 ₩174.68 Billion
≈ $118.38 Million
₩-29.16 Billion
≈ $-19.76 Million
-0.167x +32.42%
2017-12-31 ₩77.24 Billion
≈ $52.35 Million
₩-19.08 Billion
≈ $-12.93 Million
-0.247x -115.97%
2016-12-31 ₩88.75 Billion
≈ $60.14 Million
₩-10.15 Billion
≈ $-6.88 Million
-0.114x -1436.44%
2015-12-31 ₩84.65 Billion
≈ $57.37 Million
₩724.49 Million
≈ $490.97K
0.009x +104.96%
2014-12-31 ₩23.02 Billion
≈ $15.60 Million
₩-3.97 Billion
≈ $-2.69 Million
-0.173x -601.71%
2011-12-31 ₩21.19 Billion
≈ $14.36 Million
₩728.78 Million
≈ $493.89K
0.034x +164.06%
2010-12-31 ₩23.31 Billion
≈ $15.79 Million
₩303.53 Million
≈ $205.70K
0.013x --

About HLB Co. Ltd

KQ:028300 Korea Biotechnology
Market Cap
$5.41 Billion
₩7.98 Trillion KRW
Market Cap Rank
#3396 Global
#86 in Korea
Share Price
₩60800.00
Change (1 day)
-3.49%
52-Week Range
₩37000.00 - ₩68200.00
All Time High
₩120800.00
About

HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, inclu… Read more